PubRank

C Lecrubier

Author PubWeight™ 9.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A novel genetic thrombocytopenia (Paris-Trousseau) associated with platelet inclusions, dysmegakaryopoiesis and chromosome deletion AT 11q23. C R Acad Sci III 1993 0.87
2 Effects of long term administration of ticlopidine on platelet function and hemostatic variables. Thromb Res 1980 0.84
3 Acquired von Willebrand disease: correction of hemostatic defect by high-dose intravenous immunoglobulins. Am J Hematol 1992 0.82
4 Constitutional thrombocytopathy with subnormal response to thromboxane A2. Br J Haematol 1981 0.81
5 Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin. Agents Actions 1983 0.81
6 Heparin-induced thrombocytopenia: laboratory diagnosis and management. Ann Med 2000 0.81
7 Absence of in vitro cross-reaction of pentasaccharide with the plasma heparin-dependent factor of twenty-five patients with heparin-associated thrombocytopenia. Thromb Haemost 1995 0.80
8 The role of platelet factor 4 in platelet aggregation induced by the antibodies implicated in heparin-induced thrombocytopenia. Blood Coagul Fibrinolysis 2001 0.79
9 [Migraine or transient ischemic attacks in a patient with essential thrombocythaemia. Treatment with ticlopidine (author's transl)]. Ann Med Interne (Paris) 1980 0.77
10 Ultraviolet irradiation of platelet concentrates: feasibility in transfusion practice. Transfusion 1990 0.77
11 Increased sensitivity of platelets to adrenaline in human myotonic dystrophy. Lancet 1975 0.77
12 The role of UV radiation in the prevention of human leukocyte antigen alloimmunization. Transfus Med Rev 1992 0.76
13 Ticlopidine and platelet function. Thromb Haemost 1986 0.75
14 Does increased platelet aggregation have a prognostic value in the deterioration of background diabetic retinopathy? The Damad Study Group. Thromb Haemost 1990 0.75
15 Effect of prostaglandin E1 on experimental thrombosis and platelet aggregation in rabbits. Haemostasis 1974 0.75
16 [The eccentriplate device on the Dideco Vivacell cell separator for the collection of platelets]. Ann Med Interne (Paris) 1988 0.75
17 [Severe thrombocytopenia with pulmonary embolism and consumption coagulopathy during treatment with tedelparin]. Presse Med 1991 0.75
18 Oxytetracycline-induced thrombocytopenic purpura. Am J Hematol 1993 0.75
19 Familial and constitutional bleeding disorder due to platelet cyclo-oxygenase deficiency. Am J Hematol 1983 0.75
20 [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta]. J Pharmacol 1983 0.75
21 A fatal low-molecular-weight heparin-associated thrombocytopenia after hip surgery: possible usefulness of PF4-heparin ELISA test. Blood Coagul Fibrinolysis 1996 0.75
22 [Effect of a new cerebral vasodilator agent, viquidil, on the aggregation of blood platelets]. Arzneimittelforschung 1972 0.75
23 Comparative study of platelet aggregation measured with 3 different methods (photometric and impedance) in ticlopidine treated patients. Agents Actions Suppl 1984 0.75
24 [Demonstration of spontaneous platelet aggregation and research on circulating platelet aggregates: methodology, results and significance]. Ann Biol Clin (Paris) 1983 0.75
25 [Quantitative determination of Willebrand factor activity in Willebrand's disease]. Vutr Boles 1976 0.75
26 [Changes in platelet aggregation during treatment with acetylsalicylic acid. Sensitivity of various aggregating agents]. Therapie 1983 0.75
27 Platelet aggregability in 101 patients with atherothrombotic ischemic cerebral disease. J Am Med Womens Assoc 1980 0.75
28 [Experimental platelet aggregation and arterial thrombosis. Effect of aspirin]. Nouv Presse Med 1973 0.75
29 Platelet aggregation related to age in diabetes mellitus. Haemostasis 1980 0.75
30 [Platelet collection by apheresis with reduced use of citrate: quantitative and qualitative evaluation of three protocols]. Transfus Clin Biol 1995 0.75
31 [Increase in platelet sensitivity to adrenaline in Steinert's disease]. Rev Neurol (Paris) 1977 0.75
32 Original Article: Streptokinase Modifies in Vitro Platelet Aggregation by Two Mechanisms: Reduced Aggregation due to Fibrinogenolysis and Enhanced Aggregation via an Immunological Reaction. Platelets 1995 0.75
33 [Heparin-induced thrombopenia: significance and difficulties of precise identification of the immunologic mechanism]. Bull Acad Natl Med 1998 0.75
34 Letter: Abnormal factor-viii-related antigen, von Willebrand disease, and pregnancy. Lancet 1976 0.75
35 [Randiomized trial of a new platelet anti-aggregant agent: ticlopidine]. Therapie 1977 0.75
36 Persistent heparin induced thrombocytopenia despite therapy with low molecular weight heparin. Thromb Haemost 1984 0.75
37 Spontaneous platelet aggregation in heparin-treated patients. Acta Haematol 1984 0.75
38 [Study of the inhibition of blood platelet aggregation and adhesiveness by 2 soluble derivatives of acetylsalicylic acid]. Therapie 1975 0.75
39 [Critical study of the in vitro and in vivo effect of pyridinol carbamate on platelet adhesiveness and aggregation]. Therapie 1976 0.75
40 [Platelet aggregation and von Willebrand's factor in 32 insulin-dependent diabetics. Value of the measurement of filtration pressure in the presence of ADP]. Journ Annu Diabetol Hotel Dieu 1976 0.75